These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32831940)

  • 1. Anti-interleukin-6 monoclonal antibody for cytokine storm in COVID-19.
    Douedi S; Chaudhri M; Miskoff J
    Ann Thorac Med; 2020; 15(3):171-173. PubMed ID: 32831940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tocilizumab and COVID-19: Timing of Administration and Efficacy.
    Abidi E; El Nekidy WS; Alefishat E; Rahman N; Petroianu GA; El-Lababidi R; Mallat J
    Front Pharmacol; 2022; 13():825749. PubMed ID: 35250575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of tocilizumab treatment in severe and critical COVID-19 patients.
    Zeng J; Xie MH; Yang J; Chao SW; Xu EL
    World J Clin Cases; 2020 Sep; 8(17):3763-3773. PubMed ID: 32953852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Tocilizumab for the Treatment of SARS-CoV-2 Infection in a Patient With Aplastic Anemia.
    Keiffer G; French Z; Wilde L; Filicko-O'Hara J; Gergis U; Binder AF
    Front Oncol; 2020; 10():562625. PubMed ID: 33072589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 infection and its deadly cytokine storm in a young obese adult.
    Abbas S; Ahmad A; Lacasse A
    J Community Hosp Intern Med Perspect; 2020 Jul; 10(4):295-298. PubMed ID: 32850082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Use of Tocilizumab May Prevent Clinical Deterioration in Select COVID-19 Patients: A Case Series.
    Hitawala A; Kumar S; Gopalakrishna KV
    Cureus; 2020 Jul; 12(7):e9187. PubMed ID: 32818119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report.
    Chitturi KR; Thacker S; Al-Saadi MA; Kassi M
    Eur Heart J Case Rep; 2020 Oct; 4(FI1):1-6. PubMed ID: 33089052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia?
    Antinori S; Bonazzetti C; Gubertini G; Capetti A; Pagani C; Morena V; Rimoldi S; Galimberti L; Sarzi-Puttini P; Ridolfo AL
    Autoimmun Rev; 2020 Jul; 19(7):102564. PubMed ID: 32376396
    [No Abstract]   [Full Text] [Related]  

  • 9. Interleukin-6 signaling blockade treatment for cytokine release syndrome in COVID-19 (Review).
    Chen JJ; Zhang LN; Hou H; Xu L; Ji K
    Exp Ther Med; 2021 Jan; 21(1):24. PubMed ID: 33262810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weather the Cytokine Storm: A Report of Successful Management of a Colon Cancer Survivor and a Critically Ill Patient with COVID-19.
    Khalid M; Dernaika T; Jacob L; Annamaraju P; Guddati AK
    Case Rep Oncol; 2020; 13(2):754-759. PubMed ID: 32774271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tocilizumab in COVID-19: enthusiasm vs. evidence.
    Zena-Huancas P; Leon-Jimenez F; Bryce-Alberti M; Portmann-Baracco A
    Lung India; 2021; 38(6):574-576. PubMed ID: 34747742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab Use in a Chronic Hemodialysis Patient for the Management of COVID-19-Associated Pneumonia and Acute Respiratory Distress Syndrome.
    Gupta S; Madhyastha R; Hamed F; Balkis M; El Nekidy W; Attallah N
    Case Rep Nephrol; 2020; 2020():8829309. PubMed ID: 33299621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19.
    Belladonna ML; Orabona C
    Front Pharmacol; 2020; 11():959. PubMed ID: 32636755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
    Saavedra D; Añé-Kourí AL; Sánchez N; Filgueira LM; Betancourt J; Herrera C; Manso L; Chávez E; Caballero A; Hidalgo C; Lorenzo G; Cepeda M; Valenzuela C; Ramos M; León K; Mazorra Z; Crombet T
    Immun Ageing; 2020 Nov; 17(1):34. PubMed ID: 33292350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID 19 and diabetes: An endocrinologist's perspective.
    Behera KK; Hota D; Mahapatra A
    J Family Med Prim Care; 2020 Sep; 9(9):4512-4515. PubMed ID: 33209754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 Coronavirus-Induced Atypical Pneumonia: Efficacy of the Monoclonal Antibody Bevacizumab in Moderate to Severe Cases.
    Patel G; Pielykh D; Patel SM; Patel MJ; Bhavsar K; Koritala T
    Cureus; 2021 Sep; 13(9):e18317. PubMed ID: 34725588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Digital Protein Microarray for COVID-19 Cytokine Storm Monitoring.
    Song Y; Ye Y; Su SH; Stephens A; Cai T; Chung MT; Han M; Newstead MW; Frame D; Singer BH; Kurabayashi K
    medRxiv; 2020 Jun; ():. PubMed ID: 32587979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of novel coronavirus (COVID-19)-induced viral myocarditis mimicking a Takotsubo cardiomyopathy.
    Khalid Y; Dasu N; Dasu K
    HeartRhythm Case Rep; 2020 Aug; 6(8):473-476. PubMed ID: 32817822
    [No Abstract]   [Full Text] [Related]  

  • 19. Heart-Kidney Transplanted patient affected by COVID-19 pneumonia treated with tocilizumab on top of immunosuppressive maintenance therapy.
    Ammirati E; Travi G; Orcese C; Sacco A; Auricchio S; Frigerio M; Puoti M
    Int J Cardiol Heart Vasc; 2020 Aug; 29():100596. PubMed ID: 32754630
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-cytokine Therapy in Hospitalized Patients with COVID-19: The Jury is Out.
    Garg SK
    Indian J Crit Care Med; 2022 Oct; 26(10):1069-1071. PubMed ID: 36876195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.